These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 28690852)

  • 21. Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically Ill Patients.
    Yamashita C; Moriyama K; Hasegawa D; Hara Y; Kuriyama N; Nakamura T; Shibata J; Komura H; Nishida O
    Contrib Nephrol; 2018; 196():215-222. PubMed ID: 30041230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
    Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
    Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.
    Mitaka C; Kusaoi M; Kawagoe I; Satoh D
    Acute Crit Care; 2021 May; 36(2):85-91. PubMed ID: 33813808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial.
    Rachoin JS; Foster D; Giese R; Weisberg LS; Klein DJ
    Crit Care Explor; 2020 Feb; 2(2):e0083. PubMed ID: 32211615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
    Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
    Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis and septic shock.
    Hotchkiss RS; Moldawer LL; Opal SM; Reinhart K; Turnbull IR; Vincent JL
    Nat Rev Dis Primers; 2016 Jun; 2():16045. PubMed ID: 28117397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
    Terayama T; Yamakawa K; Umemura Y; Aihara M; Fujimi S
    Surg Infect (Larchmt); 2017 Apr; 18(3):225-233. PubMed ID: 28092497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
    Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
    Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
    Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
    Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
    Trials; 2014 Jun; 15():218. PubMed ID: 24916483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
    Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
    Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study.
    Marshall JC; Foster D; Vincent JL; Cook DJ; Cohen J; Dellinger RP; Opal S; Abraham E; Brett SJ; Smith T; Mehta S; Derzko A; Romaschin A;
    J Infect Dis; 2004 Aug; 190(3):527-34. PubMed ID: 15243928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial.
    Iba T; Fowler L
    J Intensive Care; 2017; 5():40. PubMed ID: 28690852
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.